scholarly article | Q13442814 |
P2093 | author name string | Johan Lökk | |
Sylvia Annerbo | |||
P2860 | cites work | Thyroid function abnormalities and cognitive impairment in elderly people: results of the Invecchiare in Chianti study | Q24645004 |
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics | Q27860914 | ||
Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study | Q28366850 | ||
Subclinical hyperthyroidism and dementia: the Sao Paulo Ageing & Health Study (SPAH). | Q33591840 | ||
Peripheral metabolism of thyroid hormones: a review. | Q34012686 | ||
Thyroid Hormones Are Associated with Poorer Cognition in Mild Cognitive Impairment | Q34168826 | ||
Effects of subclinical thyroid dysfunction on the heart | Q35012813 | ||
Drugs that suppress TSH or cause central hypothyroidism | Q35014743 | ||
Thyroid function, the risk of dementia and neuropathologic changes: the Honolulu-Asia aging study | Q35138401 | ||
G-CSF rescues the memory impairment of animal models of Alzheimer's disease | Q36229391 | ||
Thyroid function, Alzheimer's disease and postoperative cognitive dysfunction: a tale of dangerous liaisons? | Q37182300 | ||
Thyroid function and the risk of Alzheimer disease: the Framingham Study | Q37223038 | ||
Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. | Q37413422 | ||
The Thyroid Epidemiology, Audit, and Research Study (TEARS): morbidity in patients with endogenous subclinical hyperthyroidism. | Q38494383 | ||
Natural history of subclinical hyperthyroidism in elderly patients with TSH between 0.1 and 0.4 mIU/l: a prospective study | Q43072006 | ||
A prospective study on the development of Alzheimer's disease with regard to thyroid-stimulating hormone and homocysteine | Q43268303 | ||
Serum thyroxine level and cognitive decline in euthyroid older women | Q43952489 | ||
Higher free thyroxine levels predict increased incidence of dementia in older men: the Health in Men Study | Q44434682 | ||
Occurrence of Dementia in Advanced Age: The Study Design of the Kungsholmen Project | Q44688606 | ||
Low thyroid-stimulating hormone as an independent risk factor for Alzheimer disease | Q44927343 | ||
Thyroid function and cognitive decline in the MRC Cognitive Function and Ageing Study | Q45147445 | ||
[Subclinical hyperthyroidism]. | Q46801311 | ||
Thyrotropin releasing hormone (TRH) in the hippocampus of Alzheimer patients. | Q48491990 | ||
Thyroid hormones, dementia, and atrophy of the medial temporal lobe | Q48569528 | ||
A pilot study on the relationship between thyroid status and neuropsychiatric symptoms in patients with Alzheimer disease. | Q48614479 | ||
Beyond the hippocampus: MRI volumetry confirms widespread limbic atrophy in AD. | Q48713390 | ||
Endogenous subclinical thyroid disorders, physical and cognitive function, depression, and mortality in older individuals | Q48826032 | ||
Serum thyroid-stimulating hormone as a predictor of cognitive impairment in an elderly cohort. | Q51015760 | ||
Free thyroxine, cognitive decline and depression in Alzheimer's disease. | Q51909477 | ||
Is subclinical thyroid dysfunction in the elderly associated with depression or cognitive dysfunction? | Q51911425 | ||
The significance of thyroid-stimulating hormone and homocysteine in the development of Alzheimer's disease in mild cognitive impairment: a 6-year follow-up study. | Q51914328 | ||
Thyroid hormones: positive relationships with cognition in healthy, euthyroid older men. | Q52034703 | ||
Lack of association between thyroid disorders and Alzheimer's disease in older persons: a cross-sectional observational study in a geriatric outpatient population. | Q53254556 | ||
Thyroid status in senile dementia of the Alzheimer type (SDAT). | Q53303832 | ||
Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study | Q57782109 | ||
Age, sex, and serum thyrotropin concentrations in primary hypothyroidism | Q70152778 | ||
The cholinergic system in old age and Alzheimer's disease | Q71151585 | ||
Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study | Q73462518 | ||
P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
P6216 | copyright status | copyrighted | Q50423863 |
P921 | main subject | cognitive dysfunction | Q57859955 |
P304 | page(s) | 856017 | |
P577 | publication date | 2013-09-23 | |
P1433 | published in | Isrn endocrinology | Q26842873 |
P1476 | title | A clinical review of the association of thyroid stimulating hormone and cognitive impairment | |
P478 | volume | 2013 |
Q90070918 | Age-Related Resistance to Thyroid Hormone Action |
Q99589427 | Candidate variants in TUB are associated with familial tremor |
Q38993873 | Gene-based association study of genes linked to hippocampal sclerosis of aging neuropathology: GRN, TMEM106B, ABCC9, and KCNMB2. |
Q38702938 | Selenoproteins are involved in antioxidant defense systems in thalassemia |
Q26796232 | Subclinical hypothyroidism and cognitive function in people over 60 years: a systematic review and meta-analysis |
Q38327396 | Thyrotropin and Alzheimer's Disease Risk in the Elderly: a Systematic Review and Meta-Analysis |
Q36872126 | Thyroxine therapy ameliorates serum levels of eicosanoids in Chinese subclinical hypothyroidism patients. |
Q42094359 | Treating Hypothyroidism with Thyroxine/Triiodothyronine Combination Therapy in Denmark: Following Guidelines or Following Trends? |
Search more.